Enter inventor name

Kyoko Takahashi

USPTO Granted Patents = 14 (Patent Applications = 1)

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 59(Granted Patents)

Location History:

Yokohama, JP (1991 - 1996)
Tokyo, JP (1988 - 2011)

Company Filing History:

Sagami Chemical Research Center

patents

Years Active: 1988-2011

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8058231 - Transcriptional regulation of high affinity IgE receptor γ-chain (2011-11-15),

2. 7550577 - Regulation of expression of high-affinity immunoglobulin E (IgE) receptor β-chain (2009-06-23),

3. 5576467 - Method of preparing an alcohol (1996-11-19),

4. 5420286 - Optical resolution method of a nicotine derivate (1995-05-30),

5. 5254694 - Optically active epoxycyclohexane derivative and epoxycyclohexanone (1993-10-19),

6. 5210317 - Method of producing aldehyde by oxidation of primary alcohol (1993-05-11),

7. 5041566 - Method of preparing levoglucosenone (1991-08-20),

8. 4910177 - Catalyst for the reduction of aldehydes and ketones (1990-03-20),

9. 4880937 - Method of producing alcohol compounds (1989-11-14),

10. 4871858 - Method of producing formamide compounds (1989-10-03),

11. 4847424 - Method of producing aldehyde compound (1989-07-11),

12. 4841075 - Method of preparing acetal or ketal (1989-06-20),

13. 4810825 - Method of reducing nitrile into a corresponding alcohol (1989-03-07),

14. 4783559 - Process of reduction of aldehydes and ketones (1988-11-08),

Title: Kyoko Takahashi: Innovator in Immunology

Introduction

Kyoko Takahashi is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of immunology, particularly in the regulation of high-affinity immunoglobulin E (IgE) receptors. With a total of 14 patents to her name, her work has the potential to impact the treatment of various allergic and autoimmune diseases.

Latest Patents

Takahashi's latest patents focus on the transcriptional regulation of the high-affinity IgE receptor γ-chain. These patents specify transcriptional regulatory regions and factors for the human high-affinity IgE receptor (FcεRI) γ-chain gene. The inventions provide DNA sequences that regulate transcription of this gene, which could lead to the development of novel agents for the prophylaxis and treatment of allergic diseases, autoimmune diseases, thrombosis, glomerulonephritis, and lupus nephritis. Another significant patent involves the regulation of expression of the high-affinity IgE receptor β-chain. This invention includes a polynucleotide that regulates transcription of the FcεFI β-chain gene and outlines methods for promoting binding between a transcription regulatory complex and the gene's regulatory region.

Career Highlights

Throughout her career, Kyoko Takahashi has worked with notable organizations, including Japan Tobacco Inc. and Nihon University. Her research has been instrumental in advancing our understanding of immunological responses and the development of therapeutic agents.

Collaborations

Takahashi has collaborated with esteemed colleagues such as Hajime Matsushita and Makoto Shibagaki. These partnerships have further enriched her research and contributed to her innovative work in the field.

Conclusion

Kyoko Takahashi's contributions to immunology through her patents and collaborations highlight her role as a leading inventor in the field. Her work promises to pave the way for new treatments for various diseases, showcasing the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com